Basit öğe kaydını göster

Changes in antimicrobial resistance and outcomes of health care-associated infections

dc.contributor.authorErtem, Gunay Tuncer
dc.contributor.authorAydin, Mehtap
dc.contributor.authorAZAK KARALİ, EMEL
dc.contributor.authorBilgin, Huseyin
dc.contributor.authorMenekse, Sirin
dc.contributor.authorAsan, Ali
dc.contributor.authorMert, Habibe Tulin Elmaslar
dc.contributor.authorYULUĞKURAL, ZERRİN
dc.contributor.authorAltunal, Lutfiye Nilsun
dc.contributor.authorHatipoglu, Cigdem Ataman
dc.contributor.authorAltunok, Elif Sargin
dc.contributor.authorDemirkaya, Melike Hamiyet
dc.contributor.authorCeviker, Sevil Alkan
dc.contributor.authorAkgul, Fethiye
dc.contributor.authorMemis, Zeynep
dc.contributor.authorKonya, Petek
dc.contributor.authorAzap, Alpay
dc.contributor.authorAydin, Gule
dc.contributor.authorKorkmaz, Derya
dc.contributor.authorKarakoc, Zehra Cagla
dc.contributor.authorYAPAR, DERYA
dc.contributor.authorKARAKEÇİLİ, FARUK
dc.contributor.authorGunal, Ozgur
dc.contributor.authorKeske, Siran
dc.contributor.authorKapmaz, Mahir
dc.contributor.authorKADER, ÇİĞDEM
dc.contributor.authorDemirel, Aslihan
dc.contributor.authorErgonul, Onder
dc.date.accessioned2021-03-07T06:30:24Z
dc.date.available2021-03-07T06:30:24Z
dc.identifier.citationAydin M., AZAK KARALİ E., Bilgin H., Menekse S., Asan A., Mert H. T. E. , YULUĞKURAL Z., Altunal L. N. , Hatipoglu C. A. , Ertem G. T. , et al., "Changes in antimicrobial resistance and outcomes of health care-associated infections", EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2021
dc.identifier.issn0934-9723
dc.identifier.othervv_1032021
dc.identifier.otherav_f5898887-ebd2-47d8-8b66-28e5b3cf9dad
dc.identifier.urihttp://hdl.handle.net/20.500.12627/167464
dc.identifier.urihttps://doi.org/10.1007/s10096-020-04140-y
dc.description.abstractTo describe the change in the epidemiology of health care-associated infections (HAI), resistance and predictors of fatality we conducted a nationwide study in 24 hospitals between 2015 and 2018. The 30-day fatality rate was 22% in 2015 and increased to 25% in 2018. In BSI, a significant increasing trend was observed for Candida and Enterococcus. The highest rate of 30-day fatality was detected among the patients with pneumonia (32%). In pneumonia, Pseudomonas infections increased in 2018. Colistin resistance increased and significantly associated with 30-day fatality in Pseudomonas infections. Among S. aureus methicillin, resistance increased from 31 to 41%.
dc.language.isoeng
dc.subjectMikrobiyoloji
dc.subjectYaşam Bilimleri
dc.subjectTemel Bilimler
dc.subjectGeneral Immunology and Microbiology
dc.subjectImmunology
dc.subjectBULAŞICI HASTALIKLAR
dc.subjectLife Sciences
dc.subjectHealth Sciences
dc.subjectInfectious Diseases
dc.subjectİmmünoloji
dc.subjectYaşam Bilimleri (LIFE)
dc.titleChanges in antimicrobial resistance and outcomes of health care-associated infections
dc.typeMakale
dc.relation.journalEUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
dc.contributor.departmentUmraniye Res & Training Hosp Univ Hlth Sci , ,
dc.contributor.firstauthorID2528204


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster